Sofosbuvir‐based therapies in genotype 2 hepatitis C virus cirrhosis: A real‐life experience with focus on ribavirin dose

This study aimed to investigate the efficacy and safety of sofosbuvir‐based therapies for the treatment of cirrhosis from hepatitis C virus (HCV) genotype 2 infection. Data of all consecutive HCV genotype 2 cirrhotic patients who started sofosbuvir‐based treatments between January 2015 and March 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Smirne, Carlo, D'Avolio, Antonio, Bellan, Mattia, Gualerzi, Alessandro, Crobu, Maria G., Pirisi, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214994/
https://www.ncbi.nlm.nih.gov/pubmed/34152088
http://dx.doi.org/10.1002/prp2.811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214994/
https://www.ncbi.nlm.nih.gov/pubmed/34152088
http://dx.doi.org/10.1002/prp2.811

Ejemplares similares